Eli Lilly and Company Equity-NMS: LLY

Healthcare

Drug Manufacturers - General

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Previous close :$789.09
Open :$762.11
Today's high :$768.27
Today's low :$737.16
52W low :$710.1761
52W high :$969.2515
EPS(TTM): :11.68
Shares O/S :897.99 M
Market cap :664.4 B

Compare with Other Stocks

Stocks Price 1D PE Market Cap
Eli Lilly and Company $- -210.31% 70.05 664.40B

Frequently Asked Questions

What is the share price of Eli Lilly and Company today?

Eli Lilly and Company (LLY) share price as of January 1, 1970, is $. If you are investing from India, you can always check the valuation in the INR before investing.

About Eli Lilly and Company

Eli Lilly and Company is a medicine company, which discovers, develops, manufactures and markets products in the human pharmaceutical products segment. Its cardiometabolic health products include Basaglar; Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, and others; Humulin, Humulin 70/30, and others; Jardiance; Mounjaro; Trulicity; and Zepbound. Its oncology products include Cyramza, Erbitux, Tyvyt, and Verzenio. Its immunology products include Ebglyss, Olumiant, Omvoh, and Taltz. Its neuroscience products include Emgality and Kisunla. The Company, through its subsidiary, POINT Biopharma Global Inc., is engaged in radiopharmaceutical discovery, development, and manufacturing efforts, as well as clinical and pre-clinical radioligand therapies in development for the treatment of cancer. It is also developing an oral small molecule inhibitor of α4β7 integrin for inflammatory bowel disease (IBD). It also owns a lead therapeutic molecule FXR314.